{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:57:56Z","timestamp":1791190676966,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.lfs.2005.04.020","type":"journal-article","created":{"date-parts":[[2005,6,20]],"date-time":"2005-06-20T20:04:21Z","timestamp":1119297861000},"page":"2594-2602","source":"Crossref","is-referenced-by-count":43,"title":["Modifications in P62 occur due to proteasome inhibition in alcoholic liver disease"],"prefix":"10.1016","volume":"77","author":[{"given":"Fawzia","family":"Bardag-Gorce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"He Lue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel W.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2005.04.020_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/exmp.2002.2451","article-title":"The role of the ubiquitin\u2013proteasome pathway in the formation of Mallory bodies","volume":"73","author":"Bardag-Gorce","year":"2002","journal-title":"Experimental and Molecular Pathology"},{"issue":"2","key":"10.1016\/j.lfs.2005.04.020_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0014-4800(02)00024-2","article-title":"Mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1)","volume":"74","author":"Bardag-Gorce","year":"2003","journal-title":"Experimental and Molecular Pathology"},{"key":"10.1016\/j.lfs.2005.04.020_bib23","first-page":"A255","article-title":"Changes in P62 in the liver of alcohol fed rats: involvement with the ubiquitin\u2013pathway","volume":"17","author":"Bardag-Gorce","year":"2003","journal-title":"FASEB Journal"},{"issue":"1","key":"10.1016\/j.lfs.2005.04.020_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yexmp.2003.08.006","article-title":"The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation","volume":"76","author":"Bardag-Gorce","year":"2004","journal-title":"Experimental and Molecular Pathology"},{"key":"10.1016\/j.lfs.2005.04.020_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Analytical Biochemistry"},{"issue":"8","key":"10.1016\/j.lfs.2005.04.020_bib6","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/01.ALC.0000134233.89896.19","article-title":"Decreased proteasome activity is associated with increased severity of liver pathology and oxidative stress in experimental alcoholic liver disease","volume":"28","author":"Donohue","year":"2004","journal-title":"Alcohol Clinical Experimental Research"},{"issue":"1","key":"10.1016\/j.lfs.2005.04.020_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/hep.510290106","article-title":"Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress","volume":"29","author":"Fataccioli","year":"1999","journal-title":"Hepatology"},{"issue":"1\u20133","key":"10.1016\/j.lfs.2005.04.020_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-5793(02)02286-X","article-title":"Structure and functional properties of the ubiquitin binding protein P62","volume":"512","author":"Geetha","year":"2002","journal-title":"FEBS Letters"},{"key":"10.1016\/j.lfs.2005.04.020_bib24","series-title":"Guideline for the Care and Use of Laboratory Animals","author":"Institute of Laboratory Animal Resources Commission on Life Sciences National Research Council","year":"1996"},{"issue":"3","key":"10.1016\/j.lfs.2005.04.020_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1365-2990.2002.00394.x","article-title":"Early accumulation of P62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation","volume":"28","author":"Kuusisto","year":"2002","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"1","key":"10.1016\/j.lfs.2005.04.020_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/bbrc.2000.4107","article-title":"Ubiquitin-binding protein P62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells","volume":"280","author":"Kuusisto","year":"2001","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6","key":"10.1016\/j.lfs.2005.04.020_bib11","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/340731","article-title":"Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1\/P62) in Paget disease of bone","volume":"70","author":"Laurin","year":"2002","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"10.1016\/j.lfs.2005.04.020_bib12","first-page":"G118","article-title":"Mechanism of the alcohol cyclic pattern: role of the hypothalamic\u2013pituitary\u2013thyroid axis","volume":"279","author":"Li","year":"2000","journal-title":"American Journal of Physiology: Gastrointestinal and Liver Physiology"},{"issue":"4","key":"10.1016\/j.lfs.2005.04.020_bib13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/hep.20108","article-title":"Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis","volume":"39","author":"Muller","year":"2004","journal-title":"Hepatology"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2005.04.020_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2004.03.029","article-title":"Transcriptional activation of P62\/A170\/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson's disease","volume":"1012","author":"Nakaso","year":"2004","journal-title":"Brain Research"},{"key":"10.1016\/j.lfs.2005.04.020_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yexmp.2004.06.003","article-title":"P62 is involved in the mechanism of Mallory body formation","volume":"77","author":"Nan","year":"2004","journal-title":"Experimental and Molecular Pathology"},{"issue":"1","key":"10.1016\/j.lfs.2005.04.020_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/exmp.2001.2413","article-title":"The Mallory body as an aggresome: in vitro studies","volume":"72","author":"Riley","year":"2002","journal-title":"Experimental and Molecular Pathology"},{"issue":"18","key":"10.1016\/j.lfs.2005.04.020_bib18","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1128\/MCB.24.18.8055-8068.2004","article-title":"Sequestosome 1\/P62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation","volume":"24","author":"Seibenhener","year":"2004","journal-title":"Molecular and Cellular Biology"},{"issue":"5","key":"10.1016\/j.lfs.2005.04.020_bib19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1053\/jhep.2002.32674","article-title":"Mallory body\u2014a disease-associated type of sequestosome","volume":"35","author":"Stumptner","year":"2002","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2005.04.020_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.510240324","article-title":"Mallory body induction in drug-primed mouse liver","volume":"24","author":"Yuan","year":"1996","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lfs.2005.04.020_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0002-9440(10)64369-6","article-title":"P62 is a common component of cytoplasmic inclusions in protein aggregation diseases","volume":"160","author":"Zatloukal","year":"2002","journal-title":"American Journal of Pathology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320505004716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320505004716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T06:55:56Z","timestamp":1548399356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320505004716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":21,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0024320505004716"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2005.04.020","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}